| Thomas Joseph Schreiner, MD | |
|
5880 Chuckey Pike, Chuckey, TN 37641-6252 | |
| (218) 841-4573 | |
| Not Available |
| Full Name | Thomas Joseph Schreiner |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 5880 Chuckey Pike, Chuckey, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922062967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 25021 (Kentucky) | Secondary |
| 208000000X | Pediatrics | 65259 (Tennessee) | Primary |
| Entity Name | Us Health Dept Of Health & Human Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972694602 PECOS PAC ID: 9638081623 Enrollment ID: O20031106000399 |
News Archive
The City Colleges of Chicago, the largest community college system in the state of Illinois and one of the largest in the nation has joined forces with Accenture, a global management consulting, technology and outsourcing company, to ensure students are "job ready" when they graduate.
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a two-year clinical study aiming to advance the acceptance of new biomarkers designed to detect drug-induced kidney injury in clinical trials.
Fortifying grain foods with the B vitamin folic acid has saved about 1,300 babies every year from being born with serious birth defects of the brain and spine known as neural tube defects (NTDs), according to new data published by the US Centers for Disease Control and Prevention in its publication Morbidity and Mortality Weekly Report.
Hematopoietic cell transplantation (HCT), the transplantation of blood-forming stem cells from the bone marrow, peripheral blood, or umbilical cord blood, is the primary option for treatment for many patients who suffer from various hematologic disorders, including blood cancers, sickle cell disease, bone marrow deficiencies, bleeding disorders, and autoimmune disorders. Research investigating breakthroughs in hematopoietic cell transplantation will be presented today at the 53rd Annual Meeting of the American Society of Hematology.
According to a new study by researchers at Brigham and Women's Hospital (BWH), men with type 2 diabetes treated with insulin without a history of cardiovascular disease (CVD) were at higher risk for major cardiovascular events (e.g., death, heart attack, stroke) compared with men who had a history of CVD.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Joseph Schreiner, MD 5880 Chuckey Pike, Chuckey, TN 37641-6252 Ph: (218) 414-5738 | Thomas Joseph Schreiner, MD 5880 Chuckey Pike, Chuckey, TN 37641-6252 Ph: (218) 841-4573 |
News Archive
The City Colleges of Chicago, the largest community college system in the state of Illinois and one of the largest in the nation has joined forces with Accenture, a global management consulting, technology and outsourcing company, to ensure students are "job ready" when they graduate.
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a two-year clinical study aiming to advance the acceptance of new biomarkers designed to detect drug-induced kidney injury in clinical trials.
Fortifying grain foods with the B vitamin folic acid has saved about 1,300 babies every year from being born with serious birth defects of the brain and spine known as neural tube defects (NTDs), according to new data published by the US Centers for Disease Control and Prevention in its publication Morbidity and Mortality Weekly Report.
Hematopoietic cell transplantation (HCT), the transplantation of blood-forming stem cells from the bone marrow, peripheral blood, or umbilical cord blood, is the primary option for treatment for many patients who suffer from various hematologic disorders, including blood cancers, sickle cell disease, bone marrow deficiencies, bleeding disorders, and autoimmune disorders. Research investigating breakthroughs in hematopoietic cell transplantation will be presented today at the 53rd Annual Meeting of the American Society of Hematology.
According to a new study by researchers at Brigham and Women's Hospital (BWH), men with type 2 diabetes treated with insulin without a history of cardiovascular disease (CVD) were at higher risk for major cardiovascular events (e.g., death, heart attack, stroke) compared with men who had a history of CVD.
› Verified 6 days ago